3,5,7-cholestatriene

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

1.	Carotid Artery Diseases 08/01/2003 - "Among 38 subjects with no clinical manifestations of macroangiopathy and long-term good glycemic control, the 3,5,7-cholestatriene level was also significantly higher in the patients with carotid atherosclerosis than in those without it (0.40+/-0.20 vs. 0.18+/-0.12%, P=0.0003). " 08/01/2003 - "When the subjects were divided into groups with or without carotid atherosclerosis, the 3,5,7-cholestatriene level was significantly higher in 37 subjects with atherosclerosis than in 27 subjects without it (0.41+/-0.22 vs. 0.16+/-0.16%, P<0.0001). " 06/01/2006 - "Concerns about methodology and use of 3,5,7-cholestatriene as a marker of oxidative stress Response to "Relationship between carotid atherosclerosis and erythrocyte membrane cholesterol oxidation products in type 2 diabetic patients"."
2.	Atherosclerosis 08/01/2003 - "When the subjects were divided into groups with or without carotid atherosclerosis, the 3,5,7-cholestatriene level was significantly higher in 37 subjects with atherosclerosis than in 27 subjects without it (0.41+/-0.22 vs. 0.16+/-0.16%, P<0.0001). " 08/01/2003 - "These data suggest that the 3,5,7-cholestatriene level in erythrocyte membrane lipids may be a useful predictor of subclinical atherosclerosis."

1.	Glycemic Control